Vimarsana
Biggest News Aggregation in the World

Page 3 - Partb Covered News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Partb Covered. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Partb Covered Today - Breaking & Trending Today

27 Drugs Will Be Cheaper for Medicare Recipients From April - Vimarsana News

27 Drugs Will Be Cheaper for Medicare Recipients From April

Some beneficiaries of Medicare could start paying less for 27 prescription drugs beginning next month as their prices have exceeded the rate of inflation.

MedPAC Commissioners Mull Proposals to Change Part B Drug Payment - Vimarsana News

MedPAC Commissioners Mull Proposals to Change Part B Drug Payment

Reference pricing, other proposals considered

Next Steps for Healthcare and the Inflation Reduction Act | Jackson Walker - Vimarsana News

Next Steps for Healthcare and the Inflation Reduction Act | Jackson Walker

On August 16, the President signed the Inflation Reduction Act of 2022 (IRA) into law. While this post focuses on key healthcare provisions in the IRA, the law likewise has significant...

Medicare proposes to cover controversial Alzheimer's drug with restrictions - Vimarsana News

Medicare proposes to cover controversial Alzheimer's drug with restrictions

(CNN) — Medicare has proposed covering the controversial and costly Alzheimer’s drug Aduhelm only for those enrolled in qualifying clinical trials, the Centers for Medicare and Medicaid Services announced Tuesday. The agency’s decision, the latest step in the drug’s contentious path to market, would have far-reaching consequences both for millions of Alzheimer’s patients and for […]

Medicare proposes to cover controversial Alzheimer's drug with restrictions - Vimarsana News

Medicare proposes to cover controversial Alzheimer's drug with restrictions

The agency will accept public comments for 30 days and hopes to hear from Americans with Alzheimer's, their family members, patient advocacy groups, medical experts and others.

Source: komu.com